Other namesTypesCauses and contributing mechanismsSymptomsDiagnostic testsNon-Pharmacological TreatmentsDrug TreatmentsDietary Molecular SupplementsRegenerative, Immunity-Booster and Stem-Cell-Related TherapiesSurgical TreatmentsPreventionWhen to See a DoctorWhat to Eat and What to AvoidFrequently Asked QuestionsPosterior membrane corneal dystrophy is a rare eye disease that mainly affects the deepest layer of the clear front window of the eye (the cornea) and the thin sheet under it called Descemet’s membrane. In most modern eye books this condition is usually called Chandler syndrome, which is one of the three forms of iridocorneal endothelial (ICE) syndrome. In this disease, the single layer of cells on the inner surface of the cornea (endothelial cells) start to behave abnormally. They can change shape, multiply when they should not, and spread toward the colored part of the eye (iris) and the drainage angle. This abnormal behavior makes it harder for the cornea to pump out fluid, so the cornea becomes swollen and cloudy. As a result, vision can become blurred, and high eye pressure and glaucoma may develop. informatics.jax.org+4NCBI+4ScienceDirect+4Posterior membrane corneal dystrophy is an older name for a rare eye disease now usually called Chandler syndrome, a type of iridocorneal endothelial (ICE) syndrome. In this condition, the inner cell layer of the cornea (the endothelium) changes and grows abnormally. This abnormal layer can cause corneal swelling (edema), iris changes, and high eye pressure (secondary angle-closure glaucoma) that may damage the optic nerve and vision.Genetic Rare Diseases Info Center+2ZFIN+2Most people have disease in one eye only, often starting in middle age and more often in women. Symptoms can include blurred vision (especially in the morning), colored halos around lights, eye discomfort, and sometimes pain when corneal blisters (bullae) form and break.National Organization for Rare Disorders+2American Academy of Ophthalmology+2Doctors now know that posterior membrane corneal dystrophy is usually acquired (not born with it) and most often affects one eye in young or middle-aged adults, more often women. Over time, the cornea can show a hammered-metal or beaten-silver appearance and may develop blisters (epithelial bullae) and chronic edema. If the disease spreads into the drainage angle, the eye pressure can rise and damage the optic nerve, causing secondary angle-closure glaucoma. MD Searchlight+4NCBI+4Frontiers+4Other namesPosterior membrane corneal dystrophy does not have one single fixed name. Different research groups and disease databases use slightly different terms, but they are talking about the same or very closely related conditions. Common alternative names include:Chandler syndrome – this is the most widely used name today for the main clinical pattern with strong corneal changes and edema. NCBI+2EyeWiki+2Endothelial corneal dystrophy or dystrophy of corneal endothelium – these names focus on the fact that the inner corneal cell layer is the main structure that is sick. MalaCards+2informatics.jax.org+2Iridocorneal endothelial (ICE) syndrome – Chandler variant – many authors describe Chandler syndrome as one of the three ICE variants, along with progressive (essential) iris atrophy and Cogan–Reese syndrome. NCBI+2ScienceDirect+2Posterior membrane corneal dystrophy – this is treated as a synonym in several disease ontology databases for Chandler syndrome and related endothelial dystrophies, because the disease mainly involves the posterior (back) corneal membrane. MalaCards+3MalaCards+3informatics.jax.org+3These different names can be confusing. For a simple view, you can think of posterior membrane corneal dystrophy as the corneal-dominant form of ICE syndrome (Chandler pattern) where the back corneal membrane and endothelium are abnormal, leading to corneal swelling and sometimes glaucoma. Eyes On Eyecare+3EyeWiki+3NCBI+3TypesThere is no strict, official list of “types” of posterior membrane corneal dystrophy the way there is for some other corneal dystrophies. Instead, doctors describe different clinical patterns inside the same disease. These patterns help them predict symptoms and plan treatment. Dove Medical Press+3NCBI+3Frontiers+3Corneal-edema–dominant typeIn this pattern, the main problem is a swollen, cloudy cornea. The endothelial cells are very abnormal and cannot pump water out of the cornea, so fluid builds up. The patient often has blurred vision, halos around lights, and discomfort or pain due to corneal blisters. Iris changes may be minimal. PLOS+3EyeWiki+3Frontiers+3Type with early glaucoma and angle damageSome patients show strong changes in the drainage angle and early high eye pressure. The abnormal endothelial-like membrane spreads over the angle and may contract, pulling structures together and closing the drainage path. These eyes are at higher risk of severe glaucoma and optic nerve damage, sometimes even when corneal edema is not yet very advanced. Dove Medical Press+3NCBI+3ScienceDirect+3Type with marked iris distortionIn many Chandler-pattern eyes, the iris changes are mild, but in some cases there can be more visible iris atrophy, irregular pupil (corectopia), or small peripheral anterior synechiae. These iris findings still remain less dramatic than in the “essential iris atrophy” ICE variant but can help support the diagnosis. NCBI+2aao.org+2Unilateral classic typeThis is the most typical situation: only one eye is affected, with a hammered-metal corneal endothelium, focal corneal edema, and variable eye pressure. The fellow eye looks normal on exam. Most case series and reviews describe ICE syndrome and Chandler syndrome as usually unilateral and sporadic. ResearchGate+3NCBI+3ScienceDirect+3Bilateral or atypical typeIn rare reports, both eyes are affected or the pattern overlaps with other endothelial dystrophies. These unusual cases can be difficult to classify and may need advanced imaging and sometimes tissue study to separate them from congenital hereditary endothelial dystrophy (CHED) or other posterior corneal dystrophies that are also called endothelial corneal dystrophy in some catalogs. ResearchGate+3MalaCards+3ScienceDirect+3Causes and contributing mechanismsResearchers still do not know the exact single cause of posterior membrane corneal dystrophy / Chandler syndrome. Most evidence suggests it is an acquired, non-inherited endothelial cell disorder with several possible mechanisms and triggers. Dove Medical Press+3NCBI+3ScienceDirect+3Unknown primary cause (idiopathic disease)For most patients, doctors cannot find a clear trigger such as trauma or a known gene change. The condition is described as idiopathic, meaning “cause unknown.” It appears suddenly in one eye, usually in early or middle adulthood, and then slowly progresses. NCBI+2ScienceDirect+2Abnormal endothelial cell proliferationA key mechanism is that the corneal endothelial cells start to proliferate (divide) when they normally should stay as a stable, non-dividing monolayer. These cells spread onto the iris and drainage angle and produce an abnormal basement membrane, turning the back corneal surface into a kind of scar-like sheet. Dove Medical Press+3NCBI+3ScienceDirect+3Endothelial–to–epithelial–like transformationOn microscopy, the abnormal cells often look more like skin or epithelial cells than normal endothelial cells. They may form tight junctions and multilayer sheets. This change in cell identity (metaplasia) is part of the disease mechanism and helps explain how a new membrane can cover the iris and angle. NCBI+2ScienceDirect+2Abnormal basement membrane productionThe abnormal endothelial-like cells lay down a thick, uneven basement membrane on Descemet’s membrane and the iris surface. This thick membrane contracts over time, which can pull on the iris, change the pupil shape, and close the drainage angle, leading to glaucoma. ScienceDirect+2Dove Medical Press+2Failure of the corneal fluid pumpNormal endothelium pumps fluid from the corneal stroma back into the eye’s fluid space. In posterior membrane corneal dystrophy, the diseased cells cannot pump effectively. Fluid accumulates inside the cornea, causing edema and bullae, which is a major cause of blurred vision and pain. MD Searchlight+3EyeWiki+3NCBI+3Secondary angle-closure glaucomaWhen the abnormal endothelial membrane covers the drainage angle and contracts, it can close the angle or form broad peripheral anterior synechiae. This causes resistance to aqueous outflow and raises intraocular pressure, leading to secondary glaucoma. In some series, many ICE-syndrome eyes develop glaucoma during follow-up. Dove Medical Press+3NCBI+3ScienceDirect+3Iris atrophy and structural damageThe same membrane that covers the angle can also cover and pull on the iris. This can cause patchy loss of iris tissue, holes, and a displaced pupil. In Chandler syndrome the iris changes are usually mild but still considered part of the disease mechanism. MD Searchlight+3NCBI+3aao.org+3Possible viral infection trigger (hypothesis)Some earlier studies detected herpes simplex virus (HSV) DNA in corneal specimens from ICE-syndrome patients, and authors suggested that a past viral infection might trigger endothelial cell changes. Later studies, however, have not consistently confirmed this, and recent genomic work has not found strong proof of active viral infection. So viral infection is considered a possible, but unproven, trigger. PubMed+5PubMed+5ScienceDirect+5Local immune and inflammatory changesReviews of ICE syndrome suggest that local immune responses and inflammation around the corneal endothelium might help drive the disease. In some patients, inflammatory markers and immune pathways appear altered in the abnormal endothelial cells, which may help them survive and proliferate. PubMed+2ScienceDirect+2Female sex and hormonal influencesICE syndrome, including Chandler pattern, is reported more often in women. Some authors have suggested that hormones might influence corneal endothelial behavior, but there is no direct causal proof. This sex pattern is considered a risk association rather than a proven cause. NCBI+2ScienceDirect+2Middle-age onsetMany patients are diagnosed in their 20s to 50s. Age itself is not a cause, but the disease seems to appear after the cornea has been fully developed and stable for years, suggesting that an acquired factor later in life triggers the endothelial change. NCBI+2ScienceDirect+2Sporadic, non-familial occurrenceUnlike many other corneal dystrophies, posterior membrane corneal dystrophy / ICE is generally not inherited in families. Genetic testing does not show consistent gene mutations, supporting the idea that random somatic changes, environment, or local events in one eye contribute more than inherited genes. Dove Medical Press+3NCBI+3ScienceDirect+3Possible role of endothelial cell stress or injurySome researchers think any significant stress to the corneal endothelium (such as prior inflammation) might make it more likely to change and proliferate, though this is not well proven. This idea fits with the concept of an acquired localized disease but remains theoretical. Eye News+1Chronic corneal edema as a self-worsening factorOnce the cornea is swollen, oxygen and nutrient diffusion are altered, and further endothelial injury can occur. This creates a vicious cycle: abnormal endothelium causes edema, and edema further harms the endothelium, worsening the dystrophy. EyeWiki+2NCBI+2Secondary surgical and medical factorsIn some patients, prior eye surgery or long-term high eye pressure may worsen endothelial function, although these are usually consequences, not the original cause. Surgeons must be careful with intraocular surgery in ICE eyes because the already fragile endothelium can decompensate more easily. ScienceDirect+1(Points beyond this mainly expand on the same mechanisms: pump failure, membrane contraction, angle closure, and glaucoma. Current evidence does not support 20 fully separate, proven “causes,” so it is more scientifically honest to say that the main cause is unknown and the above mechanisms and associations describe how the disease develops and progresses.)SymptomsBlurred or hazy visionThe most common symptom is gradually blurred, misty, or foggy vision in one eye. This happens because the cornea becomes swollen and loses its clear, glass-like transparency. Light scatters inside the cloudy cornea instead of passing straight to the retina. MD Searchlight+4EyeWiki+4NCBI+4Halos around lightsMany patients notice rainbow-like rings or halos around bright lights, especially at night. The swollen cornea acts like a frosted window and breaks the light into rings. This can make night driving and reading digital screens very uncomfortable. EyeWiki+2NCBI+2Fluctuating vision during the dayVision can be worse in the morning when the eyes have been closed and the cornea has absorbed more fluid. As the day goes on and the eye is open, some fluid may evaporate from the surface, and vision may improve a little. This day-to-day and hour-to-hour fluctuation is common in corneal edema. EyeWiki+2NCBI+2Glare and light sensitivity (photophobia)Patients often become sensitive to bright light. Glare from sunlight, car headlights, or indoor lights can cause squinting, discomfort, and difficulty seeing clearly. This is linked to both corneal swelling and surface irregularities. PLOS+3EyeWiki+3NCBI+3Eye pain or achingWhen the cornea is very swollen, small blisters form on the surface (bullous keratopathy). These blisters can burst and expose raw nerve endings, causing sharp pain, a foreign-body sensation, or aching in the eye. Pain can also occur when eye pressure is very high. Dove Medical Press+3NCBI+3Frontiers+3Redness of the eyeSome patients show redness due to irritation, corneal epithelial damage, or high eye pressure. Redness is often more visible in advanced disease or during attacks of raised intraocular pressure. NCBI+2PLOS+2Headache or brow ache from high eye pressureIf secondary glaucoma develops, patients may get headache around the eye, brow ache, or general orbital discomfort. These symptoms often come with blurred vision, halos, and sometimes nausea when pressure is very high. MD Searchlight+3NCBI+3ScienceDirect+3Seeing a “film” or “cloud” over the eyePatients often describe the sensation as if a film is covering the eye that they cannot wipe away. This reflects diffuse corneal edema and epithelial changes that do not clear with blinking or artificial tears. EyeWiki+2NCBI+2Reduced contrast and difficulty readingEven when high-contrast letters can still be read on a chart, fine visual tasks such as reading small print, working at a computer, or recognizing faces in low light may become difficult. Corneal haze reduces contrast and sharpness. NCBI+2ScienceDirect+2Asymmetry between the two eyesSymptoms usually affect only one eye, so the patient may notice that one eye “sees worse” or “feels different.” They may cover each eye and notice a clear difference in focus, glare, or comfort. NCBI+2ScienceDirect+2Mild change in iris or pupil appearanceIn Chandler pattern, iris changes are often subtle. The pupil may look slightly off-center (corectopia), or there may be fine patches of iris thinning. Patients may not notice this themselves, but sometimes they see that the colored part of one eye looks “a little odd.” MD Searchlight+3NCBI+3aao.org+3Slow progression over yearsMany patients have slowly progressive symptoms over many years. Vision may be only mildly affected for a long time and then suddenly worsen if the cornea decompensates or glaucoma advances. This slow course is typical of ICE-related diseases. NCBI+2ScienceDirect+2Episodes of worse vision with stress or illnessSome people report that vision becomes worse during periods of stress, poor sleep, or general illness. While data on this are limited, any factor that disturbs tear film or general health can make corneal discomfort more noticeable. Dove Medical PressVisual field loss in advanced glaucomaWhen glaucoma becomes severe, patients may slowly lose parts of their side (peripheral) vision. At first, they may not notice this, but later they can bump into objects or have trouble seeing to the side while walking. This reflects optic nerve damage from chronic high pressure. MD Searchlight+3NCBI+3PLOS+3Severe visual disability in late diseaseIn the worst cases, a combination of dense corneal edema, scarring, and advanced glaucoma can cause major, sometimes permanent, vision loss. Some patients may need corneal transplant and glaucoma surgery to maintain useful sight. NCBI+2ScienceDirect+2Diagnostic testsDoctors use a set of eye exams and tests to diagnose posterior membrane corneal dystrophy and to watch for complications like glaucoma. Not every patient needs every test, but together they help give a full picture of the disease. Dove Medical Press+4NCBI+4EyeWiki+4Detailed eye history and general physical eye examThe doctor first asks about symptoms, when they started, and how they have changed. They also check the face and eyelids, look at both eyes with a light, and compare them. This basic physical exam can show redness, asymmetry, and obvious corneal clouding and helps rule out trauma or infection as other causes of corneal edema. NCBI+1Visual acuity testing (eye chart test)The patient reads letters on a distance and near chart. This test measures how clearly they can see and how much the corneal changes are affecting everyday vision. It also provides a baseline to follow over time and to check improvement after treatment or surgery. NCBI+2ScienceDirect+2Slit-lamp biomicroscopy of the corneaThis is the key manual examination. The doctor uses a special microscope with a bright, narrow light beam to examine the cornea at high magnification. In posterior membrane corneal dystrophy, they may see a beaten-metal or hammered-silver endothelial surface, microcystic edema, epithelial bullae, and sometimes nodules or membrane on the posterior surface. ResearchGate+4EyeWiki+4NCBI+4Slit-lamp exam of iris and pupilThe doctor also uses the slit lamp to inspect the iris and pupil. They look for mild iris atrophy, small holes, peripheral anterior synechiae, or pupil displacement. These findings support ICE-related disease and help distinguish Chandler pattern from other endothelial dystrophies. ResearchGate+3NCBI+3ScienceDirect+3Intraocular pressure (IOP) measurement – tonometryThe doctor measures eye pressure using applanation (Goldmann), rebound, or other forms of tonometry. High pressure suggests glaucoma or risk of glaucoma. In Chandler syndrome, IOP may be normal at first but can rise with time as the drainage angle is blocked. Dove Medical Press+3NCBI+3ScienceDirect+3Gonioscopy (examination of the drainage angle)With a special contact lens and slit lamp, the doctor looks directly at the drainage angle where fluid leaves the eye. In posterior membrane corneal dystrophy / ICE, they may see a smooth membrane, broad synechiae, or closed angle areas. This manual test shows how much the abnormal endothelium has spread and how severe the risk of glaucoma is. Dove Medical Press+3NCBI+3ScienceDirect+3Corneal pachymetry (corneal thickness measurement)Pachymetry uses ultrasound or optical devices to measure how thick the cornea is. Swollen corneas are thicker than normal, and repeated measurements help track changes over time. Very thick, edematous corneas are typical when the endothelial pump has failed. EyeWiki+2NCBI+2Specular microscopy of the corneal endotheliumSpecular microscopy is a non-invasive imaging test that shows the pattern and density of endothelial cells. In posterior membrane corneal dystrophy / ICE, the normal hexagonal pattern is replaced by abnormal, pleomorphic cells or a sheet-like membrane. Cell counts are often low or impossible to obtain. This test helps confirm that the disease is primarily endothelial. ScienceDirect+3NCBI+3ScienceDirect+3In vivo confocal microscopyConfocal microscopy provides higher-resolution images of corneal layers in a living eye. It can show details of the abnormal endothelium, the thickness and texture of Descemet’s membrane, and any scarring. It is especially useful in difficult cases to distinguish ICE-related dystrophy from other posterior corneal dystrophies like CHED or PPCD. ScienceDirect+2Genetic Eye Diseases Database+2Anterior segment optical coherence tomography (AS-OCT)AS-OCT uses light waves to create cross-section images of the front part of the eye. It can show corneal thickness, epithelial bullae, Descemet’s membrane position, and the drainage angle configuration. In ICE eyes it helps visualize peripheral anterior synechiae and angle closure without touching the eye. ScienceDirect+2ScienceDirect+2Corneal topography or tomographyTopography maps the shape and curvature of the cornea. Tomography (for example, Scheimpflug imaging) gives both front and back corneal surface data. These tests may show irregular astigmatism and posterior corneal changes in ICE-related dystrophy and help plan surgery like corneal transplantation or contact lens fitting. ResearchGate+1Standard fundus examination (back of the eye)Using indirect ophthalmoscopy and slit-lamp biomicroscopy, the doctor looks at the retina and optic nerve head. In glaucoma caused by ICE, the optic nerve may show cupping and thinning of the neuro-retinal rim. This exam is essential to judge how much damage high eye pressure has caused. NCBI+2PLOS+2Automated visual field testing (perimetry)Visual field tests measure side vision and detect areas of loss typical of glaucoma. In posterior membrane corneal dystrophy with elevated IOP, perimetry helps stage glaucoma and monitor whether treatment is protecting the optic nerve over time. NCBI+2PLOS+2Optical coherence tomography of the optic nerve and nerve fiber layerOCT scans of the optic nerve and retinal nerve fiber layer can show thinning from glaucomatous damage even before visual field loss is clear. In ICE-related glaucoma, OCT is a sensitive tool to track progression and assess how well pressure-lowering treatment is working. NCBI+2PLOS+2Laboratory and pathological study of corneal tissue (when transplanted)When a patient needs corneal transplantation, the removed corneal button can be sent for histopathology. Under the microscope, pathologists see abnormal multilayered endothelial-like cells, thick basement membrane, and sometimes viral DNA testing can be done. This is not needed for routine diagnosis but gives strong confirmation and research information. ScienceDirect+3ScienceDirect+3Dove Medical Press+3Viral PCR or serology in selected research casesIn research settings, corneal tissue or aqueous humor may be tested for herpes simplex virus or Epstein–Barr virus DNA, or blood may be examined for antibodies. These tests explore whether past viral infection played a role. They are not routine clinical tests, because the evidence for viral causation is still debated. Dove Medical Press+3PubMed+3ScienceDirect+3Ultrasound biomicroscopy (UBM) of the anterior segmentUBM uses high-frequency ultrasound to image the angle and ciliary body. It can show how far the abnormal membrane extends over the angle, how closed the angle is, and whether there are iris–angle adhesions that might explain high pressure. It is especially helpful when the cornea is too cloudy for good gonioscopy. ScienceDirect+1Electrodiagnostic tests (pattern ERG and visual evoked potentials) in advanced casesIn difficult situations where doctors are not sure how much of the vision loss comes from the cornea versus the optic nerve or brain, electrodiagnostic tests may be ordered. Pattern electroretinogram (ERG) and visual evoked potentials measure how well the retina and optic nerve carry visual signals. These tests are not specific for ICE but can help in complex glaucoma cases. Dove Medical PressRefraction and contact lens fitting assessmentCareful refraction (lens testing) can show how much of the patient’s blur is due to corneal irregularity versus other refractive errors. In milder disease, rigid gas-permeable or scleral contact lenses may improve vision by giving a smoother front surface, so this exam is important for planning conservative management. Dove Medical PressFollow-up exams to monitor progressionRepeating many of the above tests over time—visual acuity, corneal thickness, slit-lamp findings, IOP, visual fields, and OCT—allows doctors to see if the dystrophy is stable or worsening. Regular follow-up is essential because the condition can be silent at first but later cause serious glaucoma and vision loss if not monitored. Dove Medical Press+3NCBI+3ScienceDirect+3Non-Pharmacological TreatmentsThese are non-drug approaches that doctors may use to reduce symptoms, protect the cornea, and support vision. They usually work together with medicines and sometimes surgery.PubMed+2EyeWiki+2Eye protection with UV-blocking glassesWearing sunglasses that block ultraviolet (UV) light helps reduce light sensitivity and may protect the cornea from extra damage caused by UV-related oxidative stress. Large wrap-around frames also shield the eye from wind and dust, which can irritate an already swollen cornea. Good protection can make daily activities more comfortable and may slow surface irritation, although it does not cure the underlying endothelial problem.EyeWiki+1Avoiding eye rubbingRubbing the eye can worsen corneal swelling, disturb fragile epithelium, and even trigger or enlarge small blisters on the surface. In a cornea that is already stressed by endothelial failure, mechanical trauma makes pain and blurred vision worse and may speed scarring. Teaching the patient to gently tap around the orbit or use a cool compress instead of rubbing is an important behavioral therapy.PubMed+1Humidifier and environmental controlDry air from air-conditioning, heaters, or fans can irritate the ocular surface over a swollen cornea. Using a room humidifier, avoiding direct air flow to the face, and increasing indoor humidity help stabilize the tear film. A more stable tear film reduces friction with each blink and can lessen foreign-body sensation in eyes with corneal edema.EyeWiki+1Regular use of preservative-free artificial tears (as a device-like support)Although sold as “drops”, many artificial tears are considered lubricants rather than active drugs. Frequent use of preservative-free tears washes away inflammatory molecules, improves the smoothness of the front corneal surface, and reduces burning or gritty feeling. A healthier tear film also supports epithelial repair over the edematous stroma.EyeWiki+1Moisture chamber or goggles during sleepSome people sleep with slightly open eyelids, which dries the already stressed corneal surface. Wearing soft moisture goggles or taping the lids lightly (as instructed by a doctor) helps keep the cornea covered with tears and reduces morning pain and blurred vision caused by overnight exposure.EyeWiki+1Head elevation at nightCorneal edema is often worse on waking because fluid collects in the cornea when lying flat. Sleeping with the head raised on an extra pillow or an adjustable bed can reduce overnight fluid build-up. This simple method may lessen morning blurring and shorten the time needed for vision to clear after waking.EyeWiki+1Bandage contact lens (therapeutic soft lens)A thin, soft contact lens may be placed by the eye doctor to act as a “bandage” over painful epithelial bullae. It reduces friction from blinking, protects nerve endings, and can significantly decrease pain. Bandage lenses are part of standard care for painful corneal edema and must be monitored closely to avoid infection.AAO Journal+2EyeWiki+2Scleral or rigid gas-permeable (RGP) lenses for vision rehabilitationSpecial large-diameter scleral lenses vault over the irregular cornea and are filled with sterile fluid, creating a new smooth optical surface. This can greatly improve vision when glasses no longer work, even if the underlying cornea stays swollen. RGP lenses may also help in milder cases. Lens fitting must be done by an experienced contact lens specialist.American Academy of Ophthalmology+1Low-vision aids and vision rehabilitationIf corneal clarity cannot be fully restored, low-vision devices such as magnifiers, high-contrast lighting, and electronic reading aids help maintain independence. Training by a low-vision specialist teaches practical skills for reading, mobility, and work or school tasks. This is especially important if glaucoma damage also reduces vision.PLOS+1Careful control of contact lens wearIn people who already wear contact lenses, doctors may reduce wear time or switch to daily disposable lenses to lower the risk of hypoxia and infection. Over-wearing lenses can worsen edema and delay healing. Supervised, limited use or complete discontinuation may be recommended depending on corneal thickness and endothelial health.EyeWiki+1Treatment of co-existing dry eye diseaseDry eye is common and can make pain and blurred vision from corneal edema much worse. Managing meibomian gland dysfunction, using warm compresses, eyelid hygiene, and other dry-eye therapies helps stabilize the surface so that light passes more cleanly through the swollen cornea.PubMed+2MDPI+2Smoking cessationSmoking increases oxidative stress and can harm ocular surface blood flow and healing. Quitting smoking may not reverse the dystrophy, but it reduces the risk of slower wound healing after surgery and may lower the chance of other eye diseases such as macular degeneration.PMC+1Systemic disease control (blood pressure, diabetes, autoimmune disease)Good control of systemic diseases improves overall vascular health and supports microscopic blood supply to the eye. This may help the cornea and optic nerve better tolerate stress from elevated eye pressure and surgery. Poor systemic control can worsen outcomes of glaucoma and corneal transplantation.PLOS+1Infection prevention and hygieneHand-washing before touching the eye, proper care of lenses, and quick treatment of red, painful eyes reduce the risk of superimposed infections. Infection over a decompensated cornea is more dangerous and may lead to ulcers or perforation, so preventive hygiene is essential.EyeWiki+1Screen-time breaks and blink trainingLong periods on digital devices reduce blink rate, drying the ocular surface. Following the “20-20-20” rule (every 20 minutes, look 20 feet away for 20 seconds and blink fully) helps keep the tear film stable and reduces irritation over the swollen cornea.Wiley Online Library+1Cold or cool compresses (when approved by the specialist)A clean, cool (not icy) compress over closed lids can temporarily reduce discomfort and light sensitivity. Cooling slightly shrinks superficial blood vessels and numbs nerve endings. It should be used only as advised by the doctor, since excessive pressure or very cold packs can be harmful.PubMed+1Patient education and counselingUnderstanding that this is a long-term condition helps people recognize early warning signs of pressure rise or worsening edema. Education about correct drop use, adherence, and follow-up reduces the chance of silent glaucoma progression and poor transplant outcomes.PLOS+1Protecting the eye during other surgeryIf cataract or other intraocular surgery is planned, the surgeon may modify technique, choose specific lens power, and protect the endothelium with special viscoelastic substances. Planning ahead can reduce the risk of corneal decompensation after surgery.American Academy of Ophthalmology+1Occupational and driving adaptationsAdjusting lighting at work, using anti-glare filters, and checking legal driving standards help maintain safety. In some cases, limiting night driving is recommended because haloes and glare are worse in low light and with dilated pupils.Mayo Clinic+1Psychological support and support groupsLiving with chronic visual problems and repeated procedures can cause anxiety or low mood. Counseling or support groups (online or in person) help people share experiences, cope with uncertainty, and stay engaged with treatment, which in turn improves outcomes.DergiPark+1Drug TreatmentsThere is no single “cure pill” for posterior membrane corneal dystrophy. Medicines mainly treat corneal edema, pain, inflammation, and high eye pressure (glaucoma). Most eye-pressure drugs are FDA-approved for open-angle glaucoma or ocular hypertension, but are commonly used when ICE-related glaucoma is present. Always remember: only an eye specialist can decide which drug, dose, and combination is safe for you.PLOS+1Below, “Time” means typical label dosing for adults, not a personal prescription.Hypertonic sodium chloride 5% eye drops (e.g., Muro 128)Class: Ophthalmic hypertonicity agent.Use: Temporary relief of corneal edema.Mayo Clinic+3DailyMed+3FDA Access Data+3Dose / Time (typical): 1–2 drops in the affected eye up to 4 times daily, as directed on OTC labeling.Purpose & Mechanism: The highly salty solution “pulls” excess water out of the corneal stroma by osmosis, making the cornea thinner and clearer for a few hours. Side effects include stinging or burning when instilled.Hypertonic sodium chloride 5% ointment (night-time)Class: Ophthalmic hypertonicity agent.Dose / Time: A small strip inside the lower lid at bedtime.Purpose & Mechanism: Thick ointment stays on the eye longer overnight, slowly drawing fluid out of the cornea and reducing morning blur. Stinging and temporary blur after application are common.FDA Access Data+2DailyMed+2Latanoprost 0.005% eye drops (e.g., XELPROS, IYUZEH, ROCKLATAN component)Class: Prostaglandin F2α analog (glaucoma drug).FDA Access Data+3FDA Access Data+3FDA Access Data+3Dose / Time: One drop in the affected eye once daily in the evening.Purpose & Mechanism: Increases uveoscleral outflow of aqueous humor, lowering intraocular pressure (IOP) to protect the optic nerve when ICE-related glaucoma is present. Side effects include eye redness, eyelash growth, and gradual darkening of iris and eyelid skin.Timolol maleate 0.25–0.5% (e.g., TIMOPTIC, Timolol GFS)Class: Non-selective β-blocker.Federal Register Public Inspection+3FDA Access Data+3FDA Access Data+3Dose / Time: Usually 1 drop in affected eye(s) once or twice daily.Purpose & Mechanism: Reduces aqueous humor production in the ciliary body, lowering IOP. Important side effects can include slow heart rate, low blood pressure, and bronchospasm, so it is not suitable for people with asthma or serious heart disease.Brimonidine tartrate 0.1–0.2% (e.g., ALPHAGAN P, generic brimonidine)Class: α2-adrenergic agonist.DrugBank+4FDA Access Data+4FDA Access Data+4Dose / Time: One drop in affected eye(s) three times daily, about 8 hours apart.Purpose & Mechanism: Lowers IOP by decreasing aqueous production and increasing uveoscleral outflow. Common side effects are eye redness, allergic conjunctivitis, dry mouth, and fatigue.Netarsudil 0.02% (RHOPRESSA)Class: Rho-kinase (ROCK) inhibitor.NCBI+3FDA Access Data+3FDA Access Data+3Dose / Time: One drop in affected eye(s) once daily in the evening.Purpose & Mechanism: Lowers IOP by increasing trabecular outflow and lowering episcleral venous pressure. ROCK inhibitors also show promising regenerative effects on corneal endothelial cells in experimental work, so they are of special interest in endothelial disorders. Side effects include eye redness and possible corneal verticillata.Netarsudil + latanoprost (ROCKLATAN)Class: Fixed combination ROCK inhibitor + prostaglandin analog.PMC+3FDA Access Data+3NCBI+3Dose / Time: One drop once daily in the evening.Purpose & Mechanism: Combines two mechanisms to give stronger IOP reduction: increased outflow through both trabecular and uveoscleral pathways. Useful when single-agent therapy is not enough. Redness and mild cornea surface changes can occur.Topical carbonic anhydrase inhibitors (dorzolamide, brinzolamide)Class: Carbonic anhydrase inhibitors.FDA Access Data+2FDA Verification Portal+2Dose / Time: Often 1 drop 2–3 times daily, alone or in combination drops.Purpose & Mechanism: Lower IOP by reducing aqueous production. Side effects may include burning, bitter taste, and rare corneal edema or allergy; monitoring is important in already compromised corneas.Fixed combinations (dorzolamide-timolol, brinzolamide-timolol, brinzolamide-brimonidine)Class: Combination glaucoma drops.PLOS+3FDA Access Data+3FDA Verification Portal+3Dose / Time: Usually 1 drop twice daily.Purpose & Mechanism: Give stronger IOP control with fewer bottles, improving adherence. However, combined side effects of each component must be considered, especially in people with lung or heart disease.Topical corticosteroids (e.g., prednisolone acetate, loteprednol)Class: Ophthalmic corticosteroids.Dose / Time: Varies widely; often short courses (e.g., 1 drop 2–4 times daily) under close supervision.Purpose & Mechanism: Reduce inflammation from associated uveitis, post-operative inflammation, or painful bullous keratopathy. Prolonged use can raise IOP and worsen glaucoma or cause cataracts, so careful monitoring is essential.PubMed+1Topical non-steroidal anti-inflammatory drugs (NSAIDs, e.g., ketorolac)Class: Ophthalmic NSAID.Dose / Time: Typically 1 drop 3–4 times daily for short periods.Purpose & Mechanism: Decrease pain and inflammation by blocking prostaglandin synthesis. Long-term use can slow epithelial healing and increase risk of corneal melt in compromised corneas, so they must be used cautiously.PubMed+1Topical antibiotics (e.g., fluoroquinolones) when epithelial defects existClass: Broad-spectrum antibacterial eye drops.Dose / Time: Often 1 drop 4 or more times daily during high-risk periods, as directed.Purpose & Mechanism: Prevent bacterial infection in eyes with bullae or epithelial breakdown, where the surface barrier is weak. This is prophylactic rather than disease-specific therapy.EyeWiki+1Lubricating gel or ointment at night (carbomer, petrolatum-based)Class: Ocular lubricants.Dose / Time: A small strip in the lower lid at bedtime.Purpose & Mechanism: Provide thick, long-lasting lubrication and mechanical protection to the epithelium during sleep, reducing friction-related pain on waking.EyeWiki+1Systemic carbonic anhydrase inhibitor (e.g., acetazolamide tablets)Class: Systemic carbonic anhydrase inhibitor.Dose / Time: Commonly short-term courses such as 250 mg 2–4 times daily in adults for acute IOP spikes (doctor-directed only).Purpose & Mechanism: Strongly reduces aqueous humor formation and can quickly lower dangerously high IOP before surgery. Side effects include tingling, fatigue, kidney stone risk, and electrolyte imbalance, so it is not used long-term in many patients.PLOS+1Cycloplegic drops (e.g., atropine, cyclopentolate) for pain relief in selected casesClass: Anticholinergic mydriatic / cycloplegic.FDA Access DataDose / Time: Low frequency (e.g., once or twice daily) for short periods.Purpose & Mechanism: Relax the ciliary muscle and iris to reduce painful spasm and posterior synechiae risk in inflamed eyes. They may blur near vision and raise IOP in angle-closure risk eyes, so they must be used with caution in ICE.Topical ROCK inhibitors in research formulations (e.g., ripasudil, Y-27632 in studies)Class: Rho-kinase inhibitors.Dove Medical Press+3PubMed+3PubMed+3Dose / Time: Experimental dosing in clinical studies.Purpose & Mechanism: Besides lowering IOP, ROCK inhibitors promote survival and proliferation of corneal endothelial cells and may enhance their migration, offering a potential regenerative approach in endothelial diseases.Autologous serum eye drops (as an “advanced tear substitute”)Class: Blood-derived biologic tear supplement.American Academy of Ophthalmology+3PubMed+3AAO Journal+3Dose / Time: Often 6–8 times daily, prepared in special centers.Purpose & Mechanism: Contains growth factors, vitamins, and proteins similar to natural tears, supporting epithelial healing over damaged and edematous corneas. Used mainly when standard lubricants fail.Platelet-rich plasma (PRP) eye dropsClass: Blood-derived regenerative therapy.EyeWiki+4PMC+4ClinicalTrials.gov+4Dose / Time: Multiple daily instillations in supervised protocols.Purpose & Mechanism: Rich in growth factors that promote epithelial repair and may reduce recurrences of erosions in corneal surface diseases. Evidence is growing but still limited.Cenegermin-bkbj 0.002% (OXERVATE) in selected neurotrophic casesClass: Recombinant human nerve growth factor.Drugs.com+4FDA Access Data+4FDA Access Data+4Dose / Time: One drop in affected eye every 2 hours (6 times daily) for 8 weeks, per label, for neurotrophic keratitis.Purpose & Mechanism: Stimulates corneal nerve and epithelial healing. It is not licensed specifically for ICE, but might be considered if severe nerve damage co-exists.Systemic pain control (e.g., oral paracetamol / acetaminophen, as advised)Class: Systemic analgesic.Dose / Time: As per general medical guidelines, avoiding overdose.Purpose & Mechanism: Reduces systemic perception of pain from bullous keratopathy or after surgery, improving comfort while local measures treat the eye. Stronger painkillers or nerve blocks may be needed in severe cases under medical supervision.PubMed+1Dietary Molecular SupplementsSupplements may support overall eye and body health, but they do not replace medical or surgical care for posterior membrane corneal dystrophy.Omega-3 fatty acids (EPA/DHA) – Found in oily fish and fish-oil capsules; may improve dry-eye symptoms in many studies, although some large trials show mixed results. Omega-3s modulate inflammation and tear-film stability, helping comfort on top of corneal edema.ScienceDirect+3PubMed+3MDPI+3Lutein and zeaxanthin – Carotenoids that concentrate in the macula and act as antioxidants, filtering blue light and protecting retinal cells. They are linked with better overall eye health and may reduce oxidative stress that also affects the cornea indirectly.Healthline+5PMC+5ScienceDirect+5Vitamin A (within safe limits) – Essential for ocular surface health; deficiency can cause severe corneal damage and dryness. Adequate intake from diet (green leafy vegetables, orange fruits/vegetables, dairy, eggs) supports epithelial integrity over the edematous cornea. Excess vitamin A can be toxic, so dosing must be supervised.Cleveland Clinic+5EyeWiki+5PubMed+5Vitamin C – A strong antioxidant that supports collagen and wound healing. It may help corneal recovery after surgery and protect ocular tissues from oxidative damage related to chronic disease and UV exposure.PMC+1Vitamin E – Works with vitamin C and carotenoids as an antioxidant, protecting cell membranes from oxidative stress. It may be included in balanced eye-health formulations aimed at slowing degenerative changes.PMC+1Zinc and selenium – Trace elements that act as cofactors for antioxidant enzymes involved in protecting ocular tissues from oxidative damage. Adequate intake supports general immune and retinal health, indirectly helping eyes cope with chronic stress.EatingWell+1Coenzyme Q10 (CoQ10) – An antioxidant important for mitochondrial energy production; experimental and clinical studies suggest possible protective effects in retinal and glaucoma-related disease, though evidence is still evolving and not specific to Chandler syndrome.Journal Agent+5PubMed+5IOVS+5N-acetylcysteine (NAC) – A precursor of glutathione, a key intracellular antioxidant. It may help reduce oxidative damage and has been studied in some ocular surface and systemic conditions as a mucolytic and antioxidant.PubMed+1Curcumin (from turmeric) – Has anti-inflammatory and antioxidant properties in many experimental models; often taken as a nutraceutical. It may help systemic inflammation but should not be viewed as a primary treatment for corneal disease.PubMed+1Balanced multinutrient “eye formulas” – Many commercial supplements combine lutein, zeaxanthin, vitamins C and E, zinc, and sometimes omega-3s. These are designed mainly for macular and general eye health. They may be considered when diet is poor, but medical supervision is still needed to avoid overdose or interactions.AAO Journal+1Regenerative, Immunity-Booster and Stem-Cell-Related TherapiesMost of these are emerging or adjunctive options, not routine treatment for Chandler syndrome.Autologous serum eye drops – Prepared from the patient’s own blood, these drops contain growth factors, vitamins, and proteins similar to natural tears. They can improve severe ocular surface disease and persistent epithelial defects, which sometimes occur over edematous corneas.EyeWiki+5PubMed+5AAO Journal+5Platelet-rich plasma (PRP) eye drops – PRP is a blood product rich in platelets and growth factors. Studies show benefit in recurrent corneal erosions and dry eye by promoting epithelial healing and reducing recurrence of erosions.EyeWiki+4PMC+4ClinicalTrials.gov+4Topical ROCK inhibitors as pro-regenerative agents – Beyond IOP reduction, ROCK inhibitors (such as netarsudil and research agents like Y-27632 and ripasudil) promote endothelial cell proliferation and reduce cell death in models of corneal endothelial disease. They are being studied as pharmacologic support for cell-based regenerative therapy.MDPI+5PubMed+5PMC+5Cultured corneal endothelial cell injection with ROCK inhibitor (research) – Clinical studies from Japan and other centers show that injecting cultured human corneal endothelial cells into the anterior chamber together with a ROCK inhibitor can regenerate endothelium and reverse corneal edema for several years in bullous keratopathy. This represents a promising form of regenerative medicine, but it is still limited to specialized research settings.MDPI+8Nature+8PMC+8Cenegermin-bkbj (OXERVATE) as neuroregenerative therapy – This recombinant nerve growth factor is FDA-approved for neurotrophic keratitis. In eyes where both corneal nerves and surface are severely damaged, cenegermin can help re-innervate and heal the epithelium, indirectly improving comfort over an edematous cornea.Drugs.com+5FDA Access Data+5FDA Access Data+5Future stem-cell and gene-based therapies – Research is exploring stem-cell sources for corneal endothelium and gene-based approaches to endothelial disorders. These methods aim to replace or correct diseased cells rather than only treat symptoms, but they remain experimental and are not yet available for routine care.ScienceDirect+2MDPI+2Surgical TreatmentsSurgery is considered when vision is severely reduced or pain and glaucoma cannot be controlled with medicines.Endothelial keratoplasty – DMEK (Descemet Membrane Endothelial Keratoplasty)In DMEK, the surgeon removes the diseased Descemet membrane and endothelium and replaces them with only a very thin layer of healthy donor endothelium and membrane. This minimally invasive transplant is now the gold standard for many endothelial dystrophies, giving fast visual recovery and good optical quality when successful.ScienceDirect+4EyeWiki+4Mayo Clinic+4Endothelial keratoplasty – DSEK / DSAEKDSEK/DSAEK transplants a slightly thicker posterior lamellar graft (endothelium + Descemet membrane + thin stroma). It is technically easier than DMEK and still improves corneal clarity, though visual outcomes may be slightly less sharp. It is often used when anatomy or surgeon experience makes DMEK more difficult.EyeWiki+2Lippincott Journals+2Descemet stripping only / DSO (DWEK) in selected casesIn some endothelial dystrophies, surgeons can remove only a small central area of diseased Descemet membrane (“Descemet stripping only”) and allow remaining healthy peripheral endothelium to repopulate the center, sometimes supported by ROCK-inhibitor therapy. This technique is still evolving and may not be suitable for advanced Chandler syndrome but illustrates the movement toward regenerative rather than full-thickness grafting.MiEducation+2ResearchGate+2Penetrating keratoplasty (full-thickness corneal transplant)When scarring, repeated graft failure, or severe surface disease is present, a full-thickness corneal transplant may be required. The surgeon replaces the entire central cornea with donor tissue. Recovery is longer and astigmatism is more common than with endothelial keratoplasty, but this surgery can still restore vision in advanced disease.EyeWiki+2Mayo Clinic+2Glaucoma surgery (trabeculectomy, glaucoma drainage devices)ICE-related glaucoma is often difficult to control with drops alone. Filtration surgery (trabeculectomy with antifibrotic drugs) or tube shunt implants create a new outflow pathway to lower IOP. These operations are technically challenging in ICE because of abnormal angle tissue and higher risk of scarring, so they should be done by experienced glaucoma surgeons.DergiPark+4EyeWiki+4Glaucoma Today+4PreventionBecause posterior membrane corneal dystrophy is usually not caused by anything the patient did, it cannot be completely prevented. However, you can often reduce complications and slow worsening:Have regular eye exams if you notice halos, blurred vision, or one eye looking “foggy”.Control eye pressure early when glaucoma is detected to protect the optic nerve.PLOS+1Protect eyes from UV light and trauma with good eyewear.EyeWiki+1Avoid unnecessary long-term topical steroids without supervision, as they can raise IOP.PubMed+1Maintain good contact-lens hygiene and avoid over-wear.EyeWiki+1Manage systemic diseases such as diabetes and hypertension.PLOS+1Treat eye infections promptly.JAMA Network+1Eat a nutrient-rich diet with plenty of green leafy vegetables, colored fruits, and healthy fats to support overall eye health.EatingWell+1Stop smoking and avoid second-hand smoke.PMC+1Keep regular follow-ups after any corneal or glaucoma surgery so problems are detected early.PubMed+1When to See a DoctorYou should see an eye doctor urgently (same day or emergency) if:Vision suddenly becomes much more blurred or foggy in one eye.You have severe eye pain, redness, nausea, or vomiting (could be very high IOP).You see rainbow halos around lights with headache or eye ache.You notice a sudden change in pupil shape or iris appearance.Genetic Rare Diseases Info Center+2Glaucoma Today+2You should arrange a routine specialist visit if you have:Gradually worsening blur in one eye over months.Increasing glare, haloes, or trouble driving at night.A history of corneal dystrophy, ICE syndrome, or unexplained unilateral glaucoma.ZFIN+1Because you are young, it is especially important that any symptoms are evaluated by an ophthalmologist so you do not rely on internet information alone.What to Eat and What to AvoidEat: dark leafy greens (spinach, kale).Avoid excess: deep-fried foods and trans-fats that increase oxidative stress.EatingWell+1Eat: orange and yellow vegetables (carrots, sweet potatoes) for vitamin A precursors.Avoid: very high-dose vitamin A supplements without medical supervision.EyeWiki+2PubMed+2Eat: oily fish (salmon, sardines, mackerel) 1–2 times per week.Avoid: relying only on large doses of omega-3 capsules as a “cure” – they are supportive, not curative.MDPI+2Wiley Online Library+2Eat: eggs, corn, and pistachios as sources of lutein and zeaxanthin.Avoid: very high-sugar snacks that add calories but no eye-protective nutrients.Discovery Eye+2Healthline+2Eat: citrus fruits, berries, and peppers rich in vitamin C.Avoid: sugary soft drinks that replace healthier beverages.PMC+1Eat: nuts and seeds (almonds, sunflower seeds) for vitamin E and healthy fats.Avoid: heavy smoking and alcohol excess, which increase oxidative damage.EatingWell+2Healthline+2Eat: legumes and whole grains for zinc and B-vitamins.Avoid: extreme low-nutrient “junk food” diets that may lead to vitamin deficiencies.EatingWell+2American Academy of Ophthalmology+2Eat: a generally Mediterranean-style diet with fruits, vegetables, whole grains, fish, and olive oil.Avoid: very high-salt diets, which may worsen systemic hypertension that can affect eye health.MDPI+1Eat: foods rich in beta-carotene and vitamin A if your intake is low (under doctor guidance).Avoid: unregulated herbal eye “cures” that have no evidence and may interact with medicines.EyeWiki+2PubMed+2Eat: balanced meals instead of many supplements whenever possible.Avoid: assuming supplements can replace needed medical or surgical treatment for corneal disease.AAO Journal+1Frequently Asked Questions1. Is posterior membrane corneal dystrophy the same as Chandler syndrome?Yes. Modern disease databases list “posterior membrane corneal dystrophy” as a synonym for Chandler syndrome, a corneal endothelial dystrophy that is part of ICE syndrome.ZFIN+12. Can this disease affect both eyes?It usually affects one eye only, although rare bilateral cases are reported. The other eye still needs monitoring, but it often remains normal.Genetic Rare Diseases Info Center+2PMC+23. Does everyone with this condition get glaucoma?Not everyone, but many patients develop secondary angle-closure glaucoma due to abnormal endothelial tissue creeping over the drainage angle. Regular pressure checks are critical to protect the optic nerve.EyeWiki+2Glaucoma Today+24. Will eye drops cure the dystrophy?Eye drops can reduce swelling, pain, and high pressure, but they do not change the abnormal endothelial cells. The underlying dystrophy remains, so long-term follow-up and sometimes surgery are needed.PubMed+2ZFIN+25. How successful is corneal transplant surgery?Endothelial keratoplasty (DMEK/DSEK) and, when needed, penetrating keratoplasty often give good visual outcomes, especially when glaucoma is controlled. However, grafts can fail, and long-term monitoring is needed.ScienceDirect+3EyeWiki+3Lippincott Journals+36. Can ROCK inhibitor drops heal my endothelium?ROCK inhibitors like netarsudil lower IOP and show promising regenerative effects in research, but they are not yet a guaranteed cure for Chandler syndrome. They are best viewed as helpful tools within a broader treatment plan.MDPI+3NCBI+3PubMed+37. Are blood-derived drops (serum or PRP) safe?Autologous serum and PRP drops use your own blood, so allergy risk is low. They can improve severe ocular surface disease, but preparation must follow strict protocols in specialized centers, and evidence is still growing.EyeWiki+5PubMed+5AAO Journal+58. Can diet alone treat this condition?No. Diet can support general eye health and help prevent vitamin deficiencies, but it cannot reverse endothelial failure. Medical and sometimes surgical treatment are still required.EatingWell+3EyeWiki+3PubMed+39. Is the disease inherited?ICE / Chandler syndrome is usually considered non-hereditary and sporadic, unlike some other corneal dystrophies. Family members are not usually at increased genetic risk, although they should still have routine eye care.ZFIN+2Wikipedia+210. Will I lose my vision completely?Many people maintain useful vision with a combination of drops, lifestyle changes, and surgery. However, uncontrolled glaucoma or repeated graft failure can threaten vision, which is why early diagnosis and close follow-up are so important.PLOS+2Wikipedia+211. Can I wear contact lenses?In mild disease, carefully fitted lenses may be possible. In more advanced edema or after transplants, contact lenses may be limited or replaced by scleral lenses under specialist guidance. Unsafe lens habits can seriously worsen corneal problems.EyeWiki+2ResearchGate+212. Is eye surgery risky if I have this condition?Yes, surgery such as cataract extraction or glaucoma surgery is higher risk because the endothelium is fragile. However, with expert planning and modern techniques, many patients still benefit greatly from surgery. The key is to operate with a cornea-glaucoma specialist team.American Academy of Ophthalmology+2Guideline Central+213. How often should I see my eye doctor?Your doctor will decide based on severity, but many patients need visits every 3–6 months, or more often if glaucoma or recent surgery is present. Measurements of IOP, corneal thickness, and optic-nerve status guide treatment.PLOS+2PubMed+214. Can children or teenagers get Chandler syndrome?The condition mostly appears in middle-aged adults, and reports in younger patients are very rare. If a child or teenager has similar findings, doctors will carefully re-evaluate to rule out other corneal diseases.Genetic Rare Diseases Info Center+2ZFIN+215. What is the long-term outlook (prognosis)?The disease usually progresses slowly over years. With modern IOP-lowering drugs, endothelial keratoplasty, and careful follow-up, many people keep functional vision. Prognosis is poorer when glaucoma is severe or when multiple grafts fail, so early and consistent care offers the best chance for a good outcome.ScienceDirect+3PLOS+3Wikipedia+3Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.The article is written by Team RxHarun and reviewed by the Rx Editorial Board MembersLast Updated: December 21, 2025.PDF Documents For This Disease ConditionRare Diseases and Medical Genetics.[rxharun.com] i2023_IFPMA_Rare_Diseases_Brochure_28Feb2017_FINAL.[rxharun.com] the-UK-rare-diseases-framework.[rxharun.com] National-Recommendations-for-Rare-Disease-Health-Care-Summary.[rxharun.com] History of rare diseases and their genetic.[rxharun.com] health-care-and-rare-disorders.[rxharun.com] Rare Disease Registries.[rxharun.com] autoimmune-Rare-Genetic-Diseases.[rxharun.com] Rare Genetic Diseases.[rxharun.com] rare-disease-day.[rxharun.com] Rare_Disease_Drugs_e.[rxharun.com] fda-CDER-Rare-Diseases-Public-Workshop-Master.[rxharun.com] rare-and-inherited-disease-eligibility-criteria.[rxharun.com] FDA-rare-disease-list.pdf-rxharun.com1 Human-Gene-Therapy-for-Rare Diseases_Jan_2020fda.[rxharun.com]FDA-rare-disease-lists.[rxharun.com] 30212783fnl_Rare Disease.[rxharun.com] FDA-rare-disease-list.[rxharun.com] List of rare disease.[rxharun.com] Genome Res.-2025-Steyaert-755-68.[rxharun.com] uk-practice-guidelines-for-variant-classification-v4-01-2020.[rxharun.com] PIIS2949774424010355.[rxharun.com] hidden-costs-2016.[rxharun.com] B156_CONF2-en.[rxharun.com] IRDiRC_State-of-Play-2018_Final.[rxharun.com] IRDR_2022Vol11No3_pp96_160.[rxharun.com] from-orphan-to-opportunity-mastering-rare-disease-launch-excellence.[rxharun.com] Rare disease fda.[rxharun.com] England-Rare-Diseases-Action-Plan-2022.[rxharun.com] SCRDAC 2024 Report.[rxharun.com] CORD-Rare-Disease-Survey_Full-Report_Feb-2870-2.[rxharun.com] Stats-behind-the-stories-Genetic-Alliance-UK-2024.[rxharun.com] rare-and-inherited-disease-eligibility-criteria-v2.[rxharun.com] ENG_White paper_A4_Digital_FINAL.[rxharun.com] UK_Strategy_for_Rare_Diseases.[rxharun.com] MalaysiaRareDiseaseList.[rxharun.com] EURORDISCARE_FULLBOOKr.[rxharun.com] EMHJ_1999_5_6_1104_1113.[rxharun.com] national-genomic-test-directory-rare-and-inherited-disease-eligibilitycriteria-.[rxharun.com] be-counted-052722-WEB.[rxharun.com] RDI-Resource-Map-AMR_MARCH-2024.[rxharun.com] genomic-analysis-of-rare-disease-brochure.[rxharun.com] List-of-rare-diseases.[rxharun.com] RDI-Resource-Map-AFROEMRO_APRIL[rxharun.com] rdnumbers.[rxharun.com] .Rare disease atoz .[rxharun.com] EmanPublisher_12_5830biosciences-.[rxharun.com]Referenceshttps://www.ncbi.nlm.nih.gov/books/NBK208609/https://pmc.ncbi.nlm.nih.gov/articles/PMC6279436/https://rarediseases.org/rare-diseases/https://rarediseases.info.nih.gov/diseaseshttps://en.wikipedia.org/w/index.php?title=Category:Rare_diseaseshttps://en.wikipedia.org/wiki/List_of_genetic_disordershttps://en.wikipedia.org/wiki/Category:Genetic_diseases_and_disordershttps://medlineplus.gov/genetics/condition/https://geneticalliance.org.uk/support-and-information/a-z-of-genetic-and-rare-conditions/https://www.fda.gov/patients/rare-diseases-fdahttps://www.fda.gov/science-research/clinical-trials-and-human-subject-protection/support-clinical-trials-advancing-rare-disease-therapeutics-start-pilot-programhttps://accp1.onlinelibrary.wiley.com/doi/full/10.1002/jcph.2134https://www.mayoclinicproceedings.org/article/S0025-6196%2823%2900116-7/fulltexthttps://www.ncbi.nlm.nih.gov/mesh?https://www.rarediseasesinternational.org/working-with-the-who/https://ojrd.biomedcentral.com/articles/10.1186/s13023-024-03322-7https://www.rarediseasesnetwork.org/https://www.cancer.gov/publications/dictionaries/cancer-terms/def/rare-diseasehttps://www.raregenomics.org/rare-disease-listhttps://www.astrazeneca.com/our-therapy-areas/rare-disease.htmlhttps://bioresource.nihr.ac.uk/rarehttps://www.roche.com/solutions/focus-areas/neuroscience/rare-diseaseshttps://geneticalliance.org.uk/support-and-information/a-z-of-genetic-and-rare-conditions/https://www.genomicsengland.co.uk/genomic-medicine/understanding-genomics/rare-disease-genomicshttps://www.oxfordhealth.nhs.uk/cit/resources/genetic-rare-disorders/https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-022-01026https://wikicure.fandom.com/wiki/Rare_Diseaseshttps://www.wikidoc.org/index.php/List_of_genetic_disordershttps://www.medschool.umaryland.edu/btbank/investigators/list-of-disorders/https://www.orpha.net/en/disease/listhttps://www.genetics.edu.au/SitePages/A-Z-genetic-conditions.aspxhttps://ojrd.biomedcentral.com/https://health.ec.europa.eu/rare-diseases-and-european-reference-networks/rare-diseases_enhttps://bioportal.bioontology.org/ontologies/ORDOhttps://www.orpha.net/en/disease/listhttps://www.fda.gov/industry/medical-products-rare-diseases-and-conditionshttps://www.gao.gov/products/gao-25-106774https://www.gene.com/partners/what-we-are-looking-for/rare-diseaseshttps://www.genome.gov/For-Patients-and-Families/Genetic-Disordershttps://geneticalliance.org.uk/support-and-information/a-z-of-genetic-and-rare-conditions/https://my.clevelandclinic.org/health/diseases/21751-genetic-disordershttps://globalgenes.org/rare-disease-facts/https://www.nidcd.nih.gov/directory/national-organization-rare-disorders-nordhttps://byjus.com/biology/genetic-disorders/https://www.cdc.gov/genomics-and-health/about/genetic-disorders.htmlhttps://www.genomicseducation.hee.nhs.uk/doc-type/genetic-conditions/https://www.thegenehome.com/basics-of-genetics/disease-exampleshttps://www.oxfordhealth.nhs.uk/cit/resources/genetic-rare-disorders/https://www.pfizerclinicaltrials.com/our-research/rare-diseaseshttps://clinicaltrials.gov/ct2/results?recrshttps://apps.who.int/gb/ebwha/pdf_files/EB116/B116_3-en.pdfhttps://stemcellsjournals.onlinelibrary.wiley.com/doi/10.1002/sctm.21-0239https://www.nibib.nih.gov/https://www.nei.nih.gov/https://oxfordtreatment.com/https://www.nidcd.nih.gov/health/https://consumer.ftc.gov/articles/https://www.nccih.nih.gov/healthhttps://catalog.ninds.nih.gov/https://www.aarda.org/diseaselist/https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheetshttps://www.nibib.nih.gov/https://www.nia.nih.gov/health/topicshttps://www.nichd.nih.gov/https://www.nimh.nih.gov/health/topicshttps://www.nichd.nih.gov/https://www.niehs.nih.gov/https://www.nimhd.nih.gov/https://www.nhlbi.nih.gov/health-topicshttps://obssr.od.nih.gov/.https://www.nichd.nih.gov/health/topicshttps://rarediseases.info.nih.gov/diseaseshttps://beta.rarediseases.info.nih.gov/diseaseshttps://orwh.od.nih.gov/ SaveSavedRemoved 0 PreviousEndothelial Corneal Dystrophy NextChannelopathy-Associated Congenital Insensitivity to Pain, Autosomal Recessive Related ArticlesAdded to wishlistRemoved from wishlist 0 Channelopathy-Associated Congenital Insensitivity to Pain (CIP)Added to wishlistRemoved from wishlist 0 Endothelial Corneal DystrophyAdded to wishlistRemoved from wishlist 0 Dystrophy of the Corneal EndotheliumAdded to wishlistRemoved from wishlist 0 Chandler Syndrome
Added to wishlistRemoved from wishlist 0 Channelopathy-Associated Congenital Insensitivity to Pain (CIP)